You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALT

Showing 1 - 25 of 6,987
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Respiratory Distress Syndrome (ARDS) Trial (ALT-100 mAb, ALT-100 (Placebo))

Not yet recruiting
  • Acute Respiratory Distress Syndrome (ARDS)
  • ALT-100 mAb
  • ALT-100 (Placebo)
  • (no location specified)
Jul 7, 2023

Alternative Epworth Sleepiness Scale ESS-ALT in French

Not yet recruiting
  • Excessive Daytime Sleepiness
  • Test of an alternative Epworth Sleepiness Scale ESS-ALT in French
  • Ivry-sur-Seine, France
    Hospital Charles Foix
Apr 7, 2023

FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer

Completed
  • FIGO Stage III and IV Ovarian Cancer
  • +2 more
  • ALT-803 Subcutaneous
  • ALT-803 Intraperitoneal
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Oct 5, 2022

Health, Subjective Trial in Seoul (ALT-BB4, 0.9%NaCl)

Completed
  • Health, Subjective
  • Seoul, Korea, Republic of
    Research Site
Dec 12, 2022

NAFLD Trial (Diet and exercise, NAC with diet and exercise)

Not yet recruiting
  • NAFLD
  • Diet and exercise
  • NAC with diet and exercise
  • (no location specified)
Oct 26, 2022

NSCLC Trial in United States (ALT-803, Nivolumab)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • ALT-803
  • Nivolumab
  • Weston, Florida
  • +3 more
Dec 5, 2022

ARDS, Human Trial in Adelaide (ALT-100, Normal Saline)

Recruiting
  • ARDS, Human
  • Adelaide, South Australia, Australia
    CMAX Clinical Research Pty Ltd
Jul 7, 2022

Type 2 Diabetes Trial (ALT-801, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • Fort Myers, Florida
  • +6 more
Oct 11, 2022

Maxillary Protraction in Class III Adolescent After Using (MSE) Trial in Cairo (Maxillary skeletal expander with protraction

Active, not recruiting
  • Maxillary Protraction in Class III Adolescent After Using (MSE)
  • Maxillary skeletal expander with protraction face mask with Alt-RAMEC protocol.
  • Maxillary skeletal expander with protraction face mask with conventional protocol
  • Cairo, Nasr City, Egypt
    Mohamed Shendy
Aug 7, 2022

ALT Routinely Recorded Remotely: A Comparator Study of Liver

Recruiting
  • Elevated Alanine Transaminase (ALT)
  • Tasso+ SST
  • Aurora, Colorado
  • +2 more
Feb 24, 2022

Neovascular Age-related Macular Degeneration Trial in Seoul (Eylea, ALT-L9)

Completed
  • Neovascular Age-related Macular Degeneration
  • Eylea
  • ALT-L9
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 14, 2022

Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)

Active, not recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Montclair, California
  • +12 more
Oct 11, 2022

Non-Alcoholic Fatty Liver Disease Trial in Dhaka (Obeticholic acid)

Completed
  • Non-Alcoholic Fatty Liver Disease
  • Obeticholic acid
  • Dhaka, Bangladesh
    Department of Hepatology
May 15, 2022

HER2-positive Breast Cancer Trial in Daejeon (ALT-P7 (HM2-MMAE))

Completed
  • HER2-positive Breast Cancer
  • ALT-P7 (HM2-MMAE)
  • Daejeon, Korea, Republic of
    Alteogen
Jan 14, 2022

Orthodontic Appliance Complication Trial in Cairo (Intraoral protraction device, Extraoral protraction device)

Recruiting
  • Orthodontic Appliance Complication
  • Intraoral protraction device
  • Extraoral protraction device
  • Cairo, Manial, Egypt
    Faculty of Oral and dental medicine - Cairo University
Apr 19, 2022

Tongue SCC Trial (ALTF (Anterolateral thigh flap) with preoperative virtual planning, ALTF (Anterolateral thigh flap) with

Not yet recruiting
  • Tongue SCC
  • ALTF (Anterolateral thigh flap) with preoperative virtual planning
  • ALTF (Anterolateral thigh flap) with conventional method
  • (no location specified)
Aug 11, 2022

NASH - Nonalcoholic Steatohepatitis Trial in Herston (ALT-801, Placebo)

Completed
  • NASH - Nonalcoholic Steatohepatitis
  • Herston, Queensland, Australia
    Nucleus Networks
Nov 8, 2021

NASH - Nonalcoholic Steatohepatitis Trial in Herston, Adelaide (ALT-801, Metformin, Atorvastatin)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Herston, Queensland, Australia
  • +1 more
Nov 8, 2021

Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia Trial in Fuzhou (Peginterferon alpha-2b, Nucleotide Analog,

Recruiting
  • Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia
  • Peginterferon alpha-2b
  • +2 more
  • Fuzhou, Fujian, China
    Fuzhou General Hospital, Xiamen Univ
Jan 21, 2022

Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Sep 25, 2023

Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)

Active, not recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Scottsdale, Arizona
  • +14 more
Jun 30, 2022

Non-cirrhotic, Chronic Hepatitis B Trial in New Delhi (Tenofovir alafenamide fumarate)

Recruiting
  • Non-cirrhotic, Chronic Hepatitis B
  • Tenofovir alafenamide fumarate
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences (ILBS)
Feb 23, 2022

Lynch Syndrome Trial in Puerto Rico, United States (procedure, drug, other, biological)

Not yet recruiting
  • Lynch Syndrome
  • Biopsy
  • +5 more
  • Phoenix, Arizona
  • +13 more
Sep 16, 2022

Obesity/Overweight Trial in Los Angeles, Indianapolis (ALT-801, Placebo)

Active, not recruiting
  • Obesity/Overweight
  • Birmingham, Alabama
  • +30 more
Sep 7, 2022

Face Mask, Rapid Maxillary Expansion, Maxillary Retrognathism Trial in Edirne (Delaire Face Mask (M0774-01, Leone S.p.A.,

Completed
  • Face Mask
  • +2 more
  • Delaire Face Mask (M0774-01, Leone S.p.A., Florence, Italy) for first group
  • +2 more
  • Edirne, Turkey
    Trakya University
Jun 16, 2023